CARE reaffirms A- rating, revises outlook to Negative
AKSHARCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.9 pts less than its Dyes And Pigments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
CARE Ratings reaffirmed AksharChem India's bank facility ratings (CARE A-/A2+) but revised the outlook from Stable to Negative due to weak profitability. 9MFY26 showed a net loss of Rs 5.24 crore versus a profit earlier, with debt to PBILDT worsening to 8.46x. The new silica project is yet to break even.
Negative outlook flags possible future downgrade. Weak earnings and debt coverage may weigh on the stock.